AIRDF Stock Chart & Stats
$0.43
>-$0.01(-2.24%)
At close: 4:00 PM EDT
$0.43
>-$0.01(-2.24%)
Day’s Range― - ―
52-Week Range$0.35 - $0.71
Previous CloseN/A
Volume27.22K
Average Volume (3M)22.55K
Market Cap
$42.38M
Enterprise Value$58.25
Total Cash (Recent Filing)$947.65K
Total Debt (Recent Filing)$1.20M
Price to Earnings (P/E)―
Beta0.70
Next Earnings
Dec 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding101,262,250
10 Day Avg. Volume36,344
30 Day Avg. Volume22,552
Financial Highlights & Ratios
PEG Ratio-0.21
Price to Book (P/B)15.03
Price to Sales (P/S)30.35
P/FCF Ratio-8.05
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.09
Revenue Forecast (FY)$3.01M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthRevenue growth shows that the company is expanding its commercial activity from a small base, with both the latest annual period and TTM figures higher than prior levels. Continued top-line growth could improve operating leverage and provide a broader base for future investment.
Digital Healthcare PlatformThe virtual-care model addresses healthcare delivery through remote consultations and AI-supported clinical workflows. This gives the company an identifiable operating focus in digital health, where platform-based care delivery can support broader patient and clinician access over time.
Improving Free Cash Flow TrendThe improving TTM free-cash-flow trend is a limited but relevant sign that cash performance may be moving in a better direction relative to earlier periods. If sustained alongside revenue growth, this could eventually reduce the scale of funding needed for operations.
Bears Say
Severe UnprofitabilityLarge ongoing losses and negative gross profit indicate that current revenue is not covering the cost of delivering and operating the business. Without meaningful margin improvement, revenue growth alone may not translate into earnings, limiting financial resilience over the next several quarters.
Sustained Cash BurnPersistent negative operating and free cash flow shows that the business continues to consume substantial cash while funding operations. This weakens internal financing capacity and creates an ongoing need to improve cash conversion or obtain external funding to sustain the company.
Deteriorating Balance SheetThe sharp increase in leverage and decline in equity indicate a materially thinner capital cushion than in the prior year. Higher debt relative to equity can constrain financial flexibility, increase pressure during continued losses, and reduce the company’s ability to absorb further setbacks.
Rocket Doctor AI News
AIRDF FAQ
What was Rocket Doctor AI’s price range in the past 12 months?
Rocket Doctor AI lowest stock price was $0.35 and its highest was $0.71 in the past 12 months.
What is Rocket Doctor AI’s market cap?
Rocket Doctor AI’s market cap is $42.38M.
When is Rocket Doctor AI’s upcoming earnings report date?
Rocket Doctor AI’s upcoming earnings report date is Dec 01, 2026 which is in 79 days.
How were Rocket Doctor AI’s earnings last quarter?
Rocket Doctor AI released its earnings results on Aug 31, 2026. The company reported -$0.051 earnings per share for the quarter.
Is Rocket Doctor AI overvalued?
According to Wall Street analysts Rocket Doctor AI’s price is currently Overvalued.
Does Rocket Doctor AI pay dividends?
Rocket Doctor AI does not currently pay dividends.
What is Rocket Doctor AI’s EPS estimate?
Rocket Doctor AI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rocket Doctor AI have?
Rocket Doctor AI has 101,262,250 shares outstanding.
What happened to Rocket Doctor AI’s price movement after its last earnings report?
Rocket Doctor AI reported an EPS of -$0.051 in its last earnings report. Following the earnings report the stock price went down -1.199%.
Which hedge fund is a major shareholder of Rocket Doctor AI?
Currently, no hedge funds are holding shares in AIRDF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rocket Doctor AI
Rocket Doctor AI Inc., based in Vancouver, Canada, specializes in delivering personalized healthcare information services across the Canadian market. The company develops a mobile application crafted to help users assess their symptoms and effectively manage their health issues, concerns, and ongoing wellness journey. This sophisticated digital health platform also functions as an insightful assessment tool, offering valuable health analytics. Furthermore, Rocket Doctor AI Inc. provides a range of additional solutions, including medical education resources, tools for medical clinics, expert clinical advisory services, and a comprehensive healthcare information hub. Established in 2018, the company was formerly known as Treatment.com AI Inc. and is slated to officially adopt the name Rocket Doctor AI Inc. in August 2025.